SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

01 Nov 2025 Evaluate
The revenue zoomed 18.84% to Rs. 91.97 millions for the quarter ended September 2025 as compared to Rs. 77.39 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 8.17 millions  from Rs. 2.08 millions in the quarter ended September 2025.OP of the company witnessed a marginal growth to 12.85 millions from 4.79 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 91.97 77.39 18.84 166.49 184.89 -9.95 324.92 279.29 16.34
Other Income 5.65 1.31 331.30 11.19 3.93 184.73 10.24 1.76 481.82
PBIDT 12.85 4.79 168.27 23.59 11.35 107.84 27.33 17.88 52.85
Interest 0.70 0.36 94.44 0.88 0.65 35.38 1.27 1.42 -10.56
PBDT 12.15 4.43 174.27 22.71 10.70 112.24 29.47 16.46 79.04
Depreciation 1.48 1.63 -9.20 2.96 3.28 -9.76 6.29 6.62 -4.98
PBT 10.67 2.80 281.07 19.75 7.42 166.17 23.18 9.84 135.57
TAX 2.50 0.72 247.22 4.65 1.87 148.66 5.77 2.32 148.71
Deferred Tax 0.22 0.26 -15.38 0.38 0.55 -30.91 1.23 1.34 -8.21
PAT 8.17 2.08 292.79 15.10 5.55 172.07 17.41 7.52 131.52
Equity 137.21 128.73 6.59 137.63 128.73 6.91 137.63 128.73 6.91
PBIDTM(%) 13.97 6.19 125.74 14.17 6.14 130.81 8.41 6.40 31.39

Eiko Lifesciences Share Price

52.36 0.85 (1.65%)
11-Jun-2026 11:13 View Price Chart
Peers
Company Name CMP
SRF 2690.00
BASF India 3290.25
Tata Chemicals 739.80
Pidilite Inds. 1496.05
Deepak Nitrite 1646.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×